Literature DB >> 4077097

The nature of neutralization reaction between effector protein and monoclonal antibody: a quantitative study of neutralization characteristics of anti-interferon antibodies.

Y Kawade, Y Watanabe.   

Abstract

Several monoclonal antibodies to human interferon-alpha and beta were examined quantitatively for neutralization of antigenically homogeneous interferons. The extent of neutralization increased with antibody concentration in each case with a rate considerably lower than in the case of conventional (polyclonal) antibodies, and there often appeared to be a limit to the maximum interferon titre that can be neutralized, even using very high antibody concentrations (there were no such limits with conventional antibodies). This suggests that the interferon in a 1:1 interferon-antibody complex in general retains some activity, to the degree characteristic of that antibody; namely, each monoclonal antibody is considered to have a characteristic efficacy of neutralization, rather than being either neutralizing or non-neutralizing in an all-or-one fashion. The antibody dose-dependence curves were interpreted to be governed by two independent parameters of the antibody: the efficacy of neutralization and the affinity. The former is reflected by the maximum interferon titre neutralizable by high antibody doses and the latter by the minimum antibody dose that can effect detectable neutralization. Thus, quantitative neutralization tests of monoclonal antibodies to an effector protein would give useful information for classifying them as to their affinities and as to whether the epitopes they recognize are important for the biological activity of the effector.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077097      PMCID: PMC1453742     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Neutralization of activity of effector protein by monoclonal antibody: formulation of antibody dose-dependence of neutralization for an equilibrium system of antibody, effector, and its cellular receptor.

Authors:  Y Kawade
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

2.  A monoclonal antibody for large-scale purification of human leukocyte interferon.

Authors:  D S Secher; D C Burke
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

3.  The reaction of the anti-interferon-alpha monoclonal antibody, NK2, with different interferons.

Authors:  J T Whittall; R M King; D C Burke
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

4.  An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer.

Authors:  Y Kawade
Journal:  J Interferon Res       Date:  1980

5.  Specific molecular activities of recombinant and hybrid leukocyte interferons.

Authors:  E Rehberg; B Kelder; E G Hoal; S Pestka
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

6.  Neutralization of interferon by antibody: appraisals of methods of determining and expressing the neutralization titer.

Authors:  Y Kawade; Y Watanabe
Journal:  J Interferon Res       Date:  1984

7.  At least three human type alpha interferons: structure of alpha 2.

Authors:  M Streuli; S Nagata; C Weissmann
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

8.  Enhancement of monoclonal antibodies against HLA-A2 is due to antibody bivalency.

Authors:  N J Holmes; P Parham
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

9.  Different binding of human interferon alpha 1 and alpha 2 to common receptors on human and bovine cells. Studies with recombination interferons produced in Escherichia coli.

Authors:  S Yonehara; M Yonehara-Takahashi; A Ishii; S Nagata
Journal:  J Biol Chem       Date:  1983-08-10       Impact factor: 5.157

10.  Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment.

Authors:  H Arnheiter; M Ohno; M Smith; B Gutte; K C Zoon
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  4 in total

1.  Neutralization of activity of effector protein by monoclonal antibody: formulation of antibody dose-dependence of neutralization for an equilibrium system of antibody, effector, and its cellular receptor.

Authors:  Y Kawade
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

2.  Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha.

Authors:  P Kontsek; L Borecký; M Novák; E Kontseková; I Máciková
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

3.  Quantification of the neutralization of cytokine biological activity by antibody: the ten-fold reduction bioassay of interleukin-6 as growth factor.

Authors:  Sidney E Grossberg; Monika Casey; Leslie D Grossberg
Journal:  J Interferon Cytokine Res       Date:  2009-08       Impact factor: 2.607

4.  The neutralization of interferons by antibody III. The constant antibody bioassay, a highly sensitive quantitative detector of low antibody levels.

Authors:  Sidney E Grossberg; Yoshimi Kawade; Leslie D Grossberg
Journal:  J Interferon Cytokine Res       Date:  2009-02       Impact factor: 2.607

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.